Literature DB >> 22955194

PRO: osmotherapy for the treatment of acute intracranial hypertension.

Sina Grape1, Patrick Ravussin.   

Abstract

Persisting severe brain edema causes intracranial hypertension and is associated with poor patient outcome. The treatment of acute intracranial hypertension is complex and multimodal. The most important options for medical treatment include controlled ventilation and osmotherapy, maintenance of brain and body homeostasis, and sedation. Osmotherapy is recommended in all relevant guidelines. The 2 osmotic agents most frequently used are mannitol and hypertonic saline. Both reduce intracranial pressure and improve cerebral perfusion and cerebral oxygen delivery. However, hypertonic saline seems advantageous over mannitol in many situations. In multitrauma patients, hypertonic saline contributes to hemodynamic stabilization and to the prevention of secondary insults. In addition, hypertonic saline has neurohumoral and immunologic effects, which may be beneficial in cerebral resuscitation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955194     DOI: 10.1097/01.ana.0000419729.52363.64

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  5 in total

1.  Multimodal imaging in acute ischemic stroke.

Authors:  William A Copen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 2.  New trends in hyperosmolar therapy?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

3.  Ultrasonography Assessments of Optic Nerve Sheath Diameter as a Noninvasive and Dynamic Method of Detecting Changes in Intracranial Pressure.

Authors:  Li-Juan Wang; Li-Min Chen; Ying Chen; Li-Yang Bao; Nan-Nan Zheng; Yu-Zhi Wang; Ying-Qi Xing
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

4.  Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study.

Authors:  Ivayla D Yozova; Judith Howard; Diana Henke; Daniel Dirkmann; Katja N Adamik
Journal:  BMC Vet Res       Date:  2017-06-19       Impact factor: 2.741

5.  In vitro effects of 3% hypertonic saline and 20% mannitol on canine whole blood coagulation and platelet function.

Authors:  Katja-Nicole Adamik; Emmanuelle Butty; Judith Howard
Journal:  BMC Vet Res       Date:  2015-09-24       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.